Literature DB >> 1115440

"Comparably massive" penicillin G therapy in renal failure.

C S Bryan, W J Stone.   

Abstract

Impairment of penicillin G excretion in renal failure may result in life-threatening, dose-related toxicity. We report a method for achieving a desired mean serum penicillin G concentration in patients with renal failure, with minimal risk of both undertreatment and drug toxicity. The method is based on the linear relation between the total plasma clearance of penicillin G (Cpen) and the endogenous creatinine clearance. The daily maintenance dose of penicillin G (units) is defined by the product, Cpen (ml/min) times desired mean serum penicillin G concentration (mug/ml) times 2300. Application of this method to patients with various degrees of renal impairment by either constant-rate infusion or intermittent infusion gave serum penicillin G concentrations within the desired range in all but 1 of 15 instances. On the basis of these observations, practical guidelines for "comparably massive" penicillin G therapy are suggested.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115440     DOI: 10.7326/0003-4819-82-2-189

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

1.  Pharmacokinetics of nafcillin in patients with renal failure.

Authors:  C R Diaz; J G Kane; R H Parker; F R Pelsor
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

Review 2.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 3.  Pharmacokinetics of the penicillins in man.

Authors:  M Barza; L Weinstein
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

4.  Mecillinam in patients on haemodialysis.

Authors:  K Bailey; J G Cruickshank; P G Bisson; B L Radford
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 6.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

7.  Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function.

Authors:  G Humbert; D A Spyker; J P Fillastre; A Leroy
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

8.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

9.  Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis.

Authors:  Toshiaki Komatsu; Takayuki Inomata; Ichiro Watanabe; Masahiro Kobayashi; Hideya Kokubun; Junya Ako; Koichiro Atsuda
Journal:  J Pharm Health Care Sci       Date:  2016-04-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.